Alan Skarbnik, MD
Director, Lymphoma and CLL Program and Immune Effector Cell Therapeutics Program, Novant Health Cancer Institute
Session Chair
Financial Disclosure
AbbVie
Consultant
Speaker
AstraZeneca
Consultant
ADC Therapeutics
Consultant
Speaker
BMS
Consultant
Speaker
Genentech
Consultant
Speaker
GenMab
Consultant
Speaker
Incyte
Consultant
Speaker
Kite Pharma
Consultant
Speaker
Lilly
Consultant
Speaker
AstraZeneca
Speaker